Mercury Laboratories Ltd Financial Ratios
MERCURYLABORATORIESLTD · Healthcare · Current price
P/E ratio
19.9x
P/B ratio
1.7x
ROE
9.2%
ROCE
8.9%
Debt / Equity
0.14
Dividend yield
0.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 19.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 9.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 8.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.14 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Mercury Laboratories Ltd's latest numbers.
Mercury Laboratories Ltd profitability
Mercury Laboratories Ltd generates a return on equity of 9.2% and a return on capital employed of 8.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.14 and a P/E of 19.9x, Mercury Laboratories Ltd is conservatively financed. Our overall business-quality score for the company is 4.0 / 10.
Understand the ratios
More on Mercury Laboratories Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.